Les médicaments génériques sont aussi de qualité, sûrs et efficaces.
The famhp is actively involved in the management of the Ebola dossier:
Read more on the role of the famhp.
More information on:
Information for the public
A clear vision of the future - Annual report 2013
The annual report “A clear vision of the future – Annual report 2013” is available :
You can also ask for a paper copy of this annual report (as long as available) by mail to: email@example.com
To the attention of holders of MA’s: new definition for the approval date mentioned in SmPC and PIL.
When the administratively closing of a variation or renewal leads to an update of the marketing authorization (MA), a new methodology to determine the approval date mentioned in the summary of product characteristics (SmPC) and patient leaflet (PIL) will be used from 15/6/15.read more
The new edition of the electronic newsletter "VIG-NEWS" of the federal agency for medicines and health products (famhp) is now available. The VIG-NEWS is a selection of recent news concerning pharmacovigilance from different sources.read more
Due to an underemployment within the Call Center Registration in 2014, this resulted in a delay in the processing of the daily requests send to firstname.lastname@example.org. In the meantime the team has been expanded and a procedure has been worked out in order to absorb the delayed requests. As for the new requests, a workflow has been worked out in order to increase the efficiency.read more
Links to pages and documents useful for healthcare professionals
- Direct Healthcare Professional
- Field Safety Notices concerning
- Therapeutic Magistral Form (TMF)
- Unavailability of medicinal products
- RMA-materials (Risk Minimisation Activities)
- International Nonproprietary Name (INN) prescription and substitution
- Withdrawal periods (medicines for veterinary use)